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1. Attempts to control rabies by vaccinating wild carnivores with attenuated rabies virus seem very promising.
Nevertheless it is still possible to improve both the safety and the stability of the vaccine used; a recombinant vaccinia virus, expressing the immunising glycoprotein of rabies virus, has therefore been developed. Oral administration of vaccine to these target species elicits high levels of rabies virus neutralising antibodies and long-term protection against rabies, even if the virus does not multiply more than 48 hours in the tonsils.
The recombinant virus was shown to be safe for fox, raccoon, skunk, wild boar (Sus scrofa), badger (Meles meles), carrion crow (Corvus corone), magpie (Picapica), jay (Garrulus glandarius), common buzzard {Buteo buteo), kestrel (Falco tinnunculus), wood mouse (Apodemus sylvaticus), yellow-necked mouse (Apodemus flavicollis), common vole (Microtus arvalis), field vole (Microtus agrestis), water vole (Arvícola terrestris), bank vole (Clethrionomys glareolus), ferret (Mustela furo), laboratory mouse, rabbit, cattle, cat, dog and sheep, as well as numerous other non-European wildlife species.
Furthermore, the absence of horizontal transmission was confirmed in several species including the fox.
Taking into account the experimental data concerning the safety of this recombinant virus for target and non-target species and its efficacy in foxes, a first field trial of fox vaccination using the vaccinia-rabies recombinant virus was carried out in Belgium during October 1987. The results obtained confirmed the safety of this vaccine.
